// App-Quantinova.ai

: Does urinary peptide content differ between COPD patients with and without inherited alpha1-antitrypsin deficiency?

Researchers

Presenter

  • Joanna Chorostowska-Wynimko

Principal Investigators

  • Alfonso Carleo

  • Thomas Koeck

  • Mateusz Florczuk

  • Harald Mischak

  • Malgorzata Czajkowska-Malinowska

  • Adriana Rozy

  • Tobias Welte

  • Sabina Janciauskiene

Medical Centers

  • Department of Genetics and Clinical Immunology, National Institute of Tuberculosis & Lung Diseases, Warsaw, Poland

  • Institute for Pathology, Hannover Medical School, Biomedical Research in End-stage and Obstructive Lung Disease Hannover (BREATH), Hannover, Germany

  • Mosaiques Diagnostic and Therapeutics AG, Hannover, Germany

  • Mosaiques Diagnostics and Therapeutics AG, Hannover, Germany, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom

  • Department of Lung Diseases and Respiratory Failure, Regional Center of Pulmonology, Bydgoszcz, Poland

  • Department of Respiratory Medicine, Hannover Medical School, Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland, Hannover, Germany

Locations

  • Poland

  • Germany

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • Alpha-1 antitrypsin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved